House Dems Introduce Bill to Prevent Big Pharma Price Gouging During COVID-19 Pandemic
By Jessica Corbett
On the heels of polling that showed 88% of Americans worry Big Pharma will exploit the ongoing pandemic to hike drug prices, House Democrats on Monday introduced two bipartisan bills to prevent price gouging for Covid-19 treatments and vaccines and to strengthen oversight of federal spending on coronavirus research and development.
Public Citizen president Robert Weissman welcomed the legislation in a statement. "This is about way more than ensuring taxpayers aren't ripped off, as important as that objective is," he declared. "Promoting transparency and reasonable pricing of Covid-19 treatments and vaccines is a life-and-death matter."
"President Donald Trump's sycophancy to drug corporations is endangering the nation's pandemic response," Weissman warned. "Although public investments are driving drug and vaccine development, the Trump administration is permitting drug companies to retain monopoly control over the drugs and vaccines, including those still under development."
"The administration is refusing to use its existing authorities to enable knowledge sharing and generic competition. Nor is the administration seeking enhanced powers from Congress," he added. "The certain result will be profiteering, rationing, and inadequate supplies of the medicines and vaccines desperately needed to treat and eliminate the virus."
The Make Medications Affordable by Preventing Pandemic Price-gouging (MMAPPP) Act introduced Monday is sponsored by Rep. Jan Schakowsky (D-Ill.), a senior chief deputy whip and chair of the House Energy and Commerce Consumer Protection and Commerce Subcommittee. Schakowsky said that "we have good reason to be skeptical about the role of the pharmaceutical industry."
"Well before this pandemic, we saw price gouging that cost lives. Now, during a global health crisis, many pharmaceutical companies will see another opportunity to benefit themselves by 'pandemic profiteering.' That cannot stand," she said. "Congress must guarantee affordable Covid-19 drugs, eliminate monopolies on these drugs, and ensure transparency for taxpayers who developed them."
Over the past three months, Congress has appropriated BILLIONS of dollars to support research and development of… https://t.co/otYgBFWVJD— Jan Schakowsky (@Jan Schakowsky)1592854240.0
As a statement from the congresswoman's office outlined, the MMAPPP Act would prevent price-gouging by:
- Prohibiting pharmaceutical monopolies on new, taxpayer-funded Covid-19 drugs in order to ensure universal access to these drugs;
- Requiring the federal government to mandate reasonable, affordable pricing of any new, taxpayer-funded Covid-19 drug used to diagnose, mitigate, prevent, or treat Covid-19
- Ensuring transparency and requiring manufacturers to publicly report a specific breakdown of total expenditures on any Covid-19 drug, including what percentage of those expenditures were derived from federal funds; and
- Preventing excessive pricing of drug used to treat any disease that causes a public health emergency by waiving exclusive licenses and compensating with a reasonable royalty.
The second bill, the Taxpayer Research and Coronavirus Knowledge (TRACK) Act, would establish a single database for Covid-19 research and development detailing all the financial and non-financial federal support for pharmaceutical companies, information on clinical trials and patents, and the full terms of deals between the government and drug manufacturers.
"Transparency and accountability are always vital tonics to keep democracy healthy," said Rep. Lloyd Doggett (D-Texas), the bill's lead sponsor and chair of the House Ways and Means Health Subcommittee. "Crafting a new, strong oversight tool, the TRACK Act reveals to taxpayers how billions of public funds are being used—information any private investor would demand."
Both pieces of legislation are backed by Congressional Progressive Caucus Co-Chairs Mark Pocan (D-Wis.) and Pramila Jayapal (D-Wash.) as well as Reps. Peter DeFazio (D-Ore.), Rosa DeLauro (D-Conn.), and Francis Rooney (R-Fla.). DeLauro is chair of the House Labor, Health and Human Services, Education, and Related Agencies Appropriations Subcommittee, which funds the National Institutes of Health and the Biomedical Advanced Research and Development Authority.
Because of that role, DeLauro said, "I am all deeply aware of just how much money the U.S. government invests in the critical, life-saving biomedical research in this country, and we have allowed the pharmaceutical industry to take advantage of this investment, and price-gouge taxpayers. Getting any sort of information from this administration has been virtually impossible during this pandemic, and taxpayers have a right to know how their dollars are being spent."
The MMAPPP Act is endorsed by dozens of organizations, including the Center for Popular Democracy Action, Oxfam America, and Peoples Action. Supporters of the TRACK Act include AARP, Project on Government Oversight, and Communication Workers of America. Some groups—such as American Federation of Teachers, Americans for Tax Fairness, Indivisible, MomsRising, Public Citizen, and Social Security Works—support both.
"The legislative proposals from Reps. Schakowsky and Doggett prioritize public health over Big Pharma's profits," said Weissman. "Public Citizen thanks Schakowsky and Doggett for their leadership and urges immediate passage of these bills."
Reposted with permission from Common Dreams.
- Superbug Risk Rises as Big Pharma Fails to Disclose Antibiotic ... ›
- Big Pharma Emits More Greenhouse Gases Than the Automotive ... ›
- FDA Officially Belongs to Big Pharma With Senate Confirmation of ... ›
A tornado tore through a city north of Birmingham, Alabama, Monday night, killing one person and injuring at least 30.
- Tornadoes and Climate Change: What Does the Science Say ... ›
- Tornadoes Hit Unusually Wide Swaths of U.S., Alarming Climate ... ›
- 23 Dead as Tornado Pummels Lee County, AL in Further Sign ... ›
EcoWatch Daily Newsletter
By David Konisky
On his first day in office President Joe Biden started signing executive orders to reverse Trump administration policies. One sweeping directive calls for stronger action to protect public health and the environment and hold polluters accountable, including those who "disproportionately harm communities of color and low-income communities."
Michael S. Regan, President Biden's nominee to lead the U.S. Environmental Protection Agency, grew up near a coal-burning power plant in North Carolina and has pledged to "enact an environmental justice framework that empowers people in all communities." NCDEQ
- Report Urges Biden to Reverse Trump's Environmental Rollbacks ›
- US Environmental Protection Agency (EPA) ›
- Biden's EPA Pick Michael Regan Urged to Address Environmental ... ›
- Biden Faces Pressure to Tackle 'Unfunded' Toxic Waste Sites ... ›
By Katherine Kornei
Clear-cutting a forest is relatively easy—just pick a tree and start chopping. But there are benefits to more sophisticated forest management. One technique—which involves repeatedly harvesting smaller trees every 30 or so years but leaving an upper story of larger trees for longer periods (60, 90, or 120 years)—ensures a steady supply of both firewood and construction timber.
A Pattern in the Rings<p>The <a href="https://www.encyclopedia.com/science/dictionaries-thesauruses-pictures-and-press-releases/coppice-standards-0" target="_blank">coppice-with-standards</a> management practice produces a two-story forest, said <a href="https://www.researchgate.net/profile/Bernhard_Muigg" target="_blank">Bernhard Muigg</a>, a dendrochronologist at the University of Freiburg in Germany. "You have an upper story of single trees that are allowed to grow for several understory generations."</p><p>That arrangement imprints a characteristic tree ring pattern in a forest's upper story trees (the "standards"): thick rings indicative of heavy growth, which show up at regular intervals as the surrounding smaller trees are cut down. "The trees are growing faster," said Muigg. "You can really see it with your naked eye."</p><p>Muigg and his collaborators characterized that <a href="https://ltrr.arizona.edu/about/treerings" target="_blank">dendrochronological pattern</a> in 161 oak trees growing in central Germany, one of the few remaining sites in Europe with actively managed coppice-with-standards forests. They found up to nine cycles of heavy growth in the trees, the oldest of which was planted in 1761. The researchers then turned to a historical data set — more than 2,000 oak <a href="https://eos.org/articles/podcast-discovering-europes-history-through-its-timbers" target="_blank" rel="noopener noreferrer">timbers from buildings and archaeological sites</a> in Germany and France dating from between 300 and 2015 — to look for a similar pattern.</p>
A Gap of 500 Years<p>The team found wood with the characteristic coppice-with-standards tree ring pattern dating to as early as the 6th century. That was a surprise, Muigg and his colleagues concluded, because the first mention of this forest management practice in historical documents occurred only roughly 500 years later, in the 13th century.</p><p>It's probable that forest management practices were not well documented prior to the High Middle Ages (1000–1250), the researchers suggested. "Forests are mainly mentioned in the context of royal hunting interests or donations," said Muigg. Dendrochronological studies are particularly important because they can reveal information not captured by a sparse historical record, he added.</p><p>These results were <a href="https://www.nature.com/articles/s41598-020-78933-8" target="_blank">published in December in <em>Scientific Reports</em></a>.</p><p>"It's nice to see the longevity and the history of coppice-with-standards," said <a href="https://www.teagasc.ie/contact/staff-directory/s/ian-short/" target="_blank">Ian Short</a>, a forestry researcher at Teagasc, the Agriculture and Food Development Authority in Ireland, not involved in the research. This technique is valuable because it promotes conservation and habitat biodiversity, Short said. "In the next 10 or 20 years, I think we'll see more coppice-with-standards coming back into production."</p><p>In the future, Muigg and his collaborators hope to analyze a larger sample of historic timbers to trace how the coppice-with-standards practice spread throughout Europe. It will be interesting to understand where this technique originated and how it propagated, said Muigg, and there are plenty of old pieces of wood waiting to be analyzed. "There [are] tons of dendrochronological data."</p><p><em><a href="mailto:firstname.lastname@example.org" target="_blank" rel="noopener noreferrer">Katherine Kornei</a> is a freelance science journalist covering Earth and space science. Her bylines frequently appear in Eos, Science, and The New York Times. Katherine holds a Ph.D. in astronomy from the University of California, Los Angeles.</em></p><p><em>This story originally appeared in <a href="https://eos.org/articles/tree-rings-reveal-how-ancient-forests-were-managed" target="_blank">Eos</a></em> <em>and is republished here as part of Covering Climate Now, a global journalism collaboration strengthening coverage of the climate story.</em></p>
Earth's ice is melting 57 percent faster than in the 1990s and the world has lost more than 28 trillion tons of ice since 1994, research published Monday in The Cryosphere shows.
By Jewel Fraser
Noreen Nunez lives in a middle-class neighborhood that rises up a hillside in Trinidad's Tunapuna-Piarco region.